Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2012-08-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Racial and Aging Effects of Acute Antioxidant Supplementation
NCT02157207
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
NCT06369350
Examining Endogenous Antioxidant Levels in Well Trained Cyclists
NCT02281851
Effect of Short-term Annatto Carotenoids Supplementation on Oxidative Stress Status in Healthy Individuals
NCT03820245
The Effect of Antioxidant Vitamin Supplementation on Muscle Performance and Redox Status After Eccentric Training
NCT01290458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
Control trial to determine the impact of the ischemic injury on vascular function without intervention
No interventions assigned to this group
Antioxidant load
Trial to determine the impact of an antioxidant load before the ischemic injury on vascular function recovery
Antioxidant
Prostaglandin inhibition
Trial to determine the impact of a non-selective prostaglandin inhibitor before the ischemic injury on vascular function recovery
Prostaglandin inhibitor (Ibuprophen)
Combined
Trial to determine the impact of an antioxidant load and prostaglandin inhibitor before the ischemic injury on vascular function recovery
Antioxidant
Prostaglandin inhibitor (Ibuprophen)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antioxidant
Prostaglandin inhibitor (Ibuprophen)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy females
Exclusion Criteria
* Cardiovascular disease
* Peripheral vascular disease
* Neurological deficits
* Diabetes Type I or II
* Pregnant women
* Adverse reactions to Ibuprofen
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Essex
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Rakobowchuk
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Rakobowchuk, PhD
Role: PRINCIPAL_INVESTIGATOR
Thompson Rivers University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Essex
Colchester, Essex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DBD0300
Identifier Type: OTHER
Identifier Source: secondary_id
IRAPC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.